Publications by authors named "Remi Tanaka"

Claim this Profile
B
Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells.
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, Kana Kishimoto, Remi Tanaka

Clin Exp Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression.
Tomoya Takeda, Masanobu Tsubaki, Shuji Genno, Kenta Tokunaga, Remi Tanaka

Int J Mol Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells.
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, Akihiro Kimura, Remi Tanaka

BMB Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis